In The News

Michael Rickels, MD, MSPacreatic Islet Cell Transplatation Restores Type 1 Diabetes Patients' Ability to Defend Against Life Threatening Low Blood Sugar, According to Penn Medicine Study.

Type 1 diabetes (T1D) patients who have developed low blood sugar (hypoglycemia) as a complication of insulin treatments over time are able to regain normal internal recognition of the condition after receiving pancreatic islet cell transplantation, according to a new study led led by Michael R. Rickels, MD, MS, associate professor of Medicine and medical director of the Pancreatic Islet Cell Transplant Program and other researchers at the Perelman School of Medicine at the University of Pennsylvania, published online in Diabetes.  >> Penn Medicine News Release


Spring 2015 Seminar Series

Spring 2015 Seminar Series

Seminars and Events:


2015 Spring Symposium & Kroc Lecture

March 17, 2015
2015 Spring Symposium & Kroc Lecture